Based on the key indicators obtained from Evolent Health's historical financial statements, Evolent Health is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December. As of now, Evolent Health's Net Debt is increasing as compared to previous years. The Evolent Health's current Accounts Payable is estimated to increase to about 48.9 M, while Total Stockholder Equity is projected to decrease to under 706.1 M. Key indicators impacting Evolent Health's financial strength include:
Investors should never underestimate Evolent Health's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Evolent Health's cash flow, debt, and profitability to make informed and accurate decisions about investing in Evolent Health.
Cash And Equivalents
231.91 Million
Evolent
Select Account or Indicator
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Sale Purchase Of Stock
Change To Inventory
Change To Liabilities
Investments
Net Borrowings
Total Cashflows From Investing Activities
Change To Operating Activities
Other Cashflows From Investing Activities
Change To Netincome
Change Receivables
Dividends Paid
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Cash And Short Term Investments
Net Receivables
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Other Current Assets
Other Stockholder Equity
Total Liab
Total Current Assets
Intangible Assets
Other Liab
Current Deferred Revenue
Short Term Investments
Non Current Liabilities Total
Inventory
Property Plant And Equipment Gross
Accumulated Other Comprehensive Income
Short Term Debt
Property Plant Equipment
Net Tangible Assets
Long Term Debt
Good Will
Common Stock Total Equity
Deferred Long Term Liab
Long Term Investments
Common Stock
Total Permanent Equity
Noncontrolling Interest In Consolidated Entity
Retained Earnings Total Equity
Capital Surpluse
Additional Paid In Capital
Non Current Liabilities Other
Short Long Term Debt Total
Long Term Debt Total
Short Long Term Debt
Cash And Equivalents
Net Invested Capital
Net Working Capital
Capital Stock
Capital Lease Obligations
Depreciation And Amortization
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Interest Expense
Selling General Administrative
Research Development
Net Income From Continuing Ops
Non Recurring
Net Income Applicable To Common Shares
Minority Interest
Tax Provision
Interest Income
Non Operating Income Net Other
Net Interest Income
Reconciled Depreciation
Extraordinary Items
Discontinued Operations
Probability Of Bankruptcy
Understanding current and past Evolent Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Evolent Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Evolent Health's assets may result in an increase in income on the income statement.
Evolent Health competes with HealthStream, National Research, HealthEquity, Health Catalyst, and Definitive Healthcare. Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. The company was founded in 2011 and is headquartered in Arlington, Virginia. Evolent Health operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 3500 people.
Comparative valuation techniques use various fundamental indicators to help in determining Evolent Health's current stock value. Our valuation model uses many indicators to compare Evolent Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evolent Health competition to find correlations between indicators driving Evolent Health's intrinsic value. More Info.
Evolent Health is rated # 4 in return on equity category among its peers. It also is rated # 4 in return on asset category among its peers . As of now, Evolent Health's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evolent Health's earnings, one of the primary drivers of an investment's value.
Evolent Health Systematic Risk
Evolent Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Evolent Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Evolent Health correlated with the market. If Beta is less than 0 Evolent Health generally moves in the opposite direction as compared to the market. If Evolent Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Evolent Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Evolent Health is generally in the same direction as the market. If Beta > 1 Evolent Health moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Evolent Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Evolent Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Evolent Health growth as a starting point in their analysis.
Evolent Health November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Evolent Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Evolent Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Evolent Health based on widely used predictive technical indicators. In general, we focus on analyzing Evolent Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Evolent Health's daily price indicators and compare them against related drivers.
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.